KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Change in Cash (2016 - 2025)

Historic Change in Cash for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $3.1 billion.

  • Bristol Myers Squibb's Change in Cash rose 9505.32% to $3.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 billion, marking a year-over-year increase of 231015.38%. This contributed to the annual value of -$1.2 billion for FY2024, which is 15341.84% down from last year.
  • Per Bristol Myers Squibb's latest filing, its Change in Cash stood at $3.1 billion for Q3 2025, which was up 9505.32% from $1.7 billion recorded in Q2 2025.
  • In the past 5 years, Bristol Myers Squibb's Change in Cash registered a high of $4.0 billion during Q4 2023, and its lowest value of -$3.7 billion during Q1 2021.
  • Moreover, its 5-year median value for Change in Cash was $76.0 million (2021), whereas its average is $39.6 million.
  • In the last 5 years, Bristol Myers Squibb's Change in Cash skyrocketed by 59442.23% in 2021 and then tumbled by 223026.32% in 2022.
  • Over the past 5 years, Bristol Myers Squibb's Change in Cash (Quarter) stood at $437.0 million in 2021, then skyrocketed by 213.04% to $1.4 billion in 2022, then soared by 188.82% to $4.0 billion in 2023, then plummeted by 37.89% to $2.5 billion in 2024, then increased by 26.94% to $3.1 billion in 2025.
  • Its last three reported values are $3.1 billion in Q3 2025, $1.7 billion for Q2 2025, and $528.0 million during Q1 2025.